Balaxi Pharmaceuticals Ltd.

View in App
422.00 -1.45 ▼-0.3%

11 December 2023, 03:41:50 PM
Volume: 2,581

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.balaxipharma.in
Market Cap 431.71 Cr.
Enterprise Value(EV) 450.45 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -10.35 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-09
Industry PE 38.37 Trailing Twelve Months Ending 2023-09
Book Value / Share 144.55 Trailing Twelve Months Ending 2023-09
Price to Book Value 2.92 Calculated using Price: 422.00
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.02 Cr. 10,230,200 Shares
FaceValue 10
About Balaxi Pharmaceuticals Ltd.
The company is engaged in the business of international wholesale trading of Pharmaceuticals, Builders Hardware and FMCG products

Balaxi Pharmaceuticals Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Balaxi Pharmaceuticals Ltd. Performance

View details >>
1 Day
-0.34%
1 Week
+2.15%
1 Month
+0.55%
3 Month
-10.33%
6 Month
-19.41%
1 Year
-26.65%
2 Year
-19.04%
5 Year
+1380.70%
10 Year

Balaxi Pharmaceuticals Ltd. Fundamental Ratios

View details >>
5 years 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 55.84 39.04 82.26 53.50 32.17
Return on Capital Employed (%) 69.35 56.56 92.56 59.62 37.46
Return on Assets (%) 32.19 29.01 56.23 34.52 22.09

Balaxi Pharmaceuticals Ltd. Balance Sheet

View details >>
Particulars 6 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 4 28 65 113 183 155
Non Curr. Liab. 0 0 4 3
Curr. Liab. 3 8 35 63 53 56
Minority Int.
Equity & Liab. 6 36 100 176 240 214
Non Curr. Assets 0 1 6 35 46 51
Curr. Assets 6 35 94 141 194 163
Misc. Exp. not W/O
Total Assets 6 36 100 176 240 214

Balaxi Pharmaceuticals Ltd. Profit and Loss

View details >>
Particulars 6 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 14 46 231 279 336 288
Other Income 1 1 2 5 3 -6
Total Income 14 46 234 284 339 282
Total Expenditure -12 -37 -189 -229 -279 -240
PBIDT 2 9 45 56 60 42
Interest 0 0 -1 -1 -1
Depreciation 0 0 -1 -2 -2
Taxation 0 -3 -6 -7 -11 -8
Exceptional Items -41
PAT 2 6 38 48 46 -11
Minority Interest
Share Associate
Other Related Items -1 1 6
Consolidated Net Profit 2 6 37 48 52 -11
Adjusted EPS 6 6 37 48 51 -10

Balaxi Pharmaceuticals Ltd. Cash Flow

View details >>
Particulars 5 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -2 -14 34 6
Cash Fr. Inv. 0 0 -6 -28 -11
Cash Fr. Finan. 18 4 0 26
Net Change -2 4 -2 6 21
Cash & Cash Eqvt 0 4 2 7 28

Balaxi Pharmaceuticals Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 72.86 72.86 72.86 72.86 72.86 72.69 71.57 71.22 71.22
Public 27.13 27.14 27.14 27.14 27.14 27.31 28.43 28.78 28.78
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Balaxi Pharmaceuticals Ltd. Announcements

View details >>
Fri, 03 Nov 2023
Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
Fri, 03 Nov 2023
Outcome of Board Meeting
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Outcome of Board Meeting held on November 02, 2023.
Fri, 03 Nov 2023
Outcome of Board Meeting
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Board meeting held on November 02, 2023.

Balaxi Pharmaceuticals Ltd. Technical Scans

View details >>
Mon, 11 Dec 2023
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease in 6 Months High Decrease in 6 Months
High Increase in 5 Years High Increase in 5 Years

Balaxi Pharmaceuticals Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 297,829.45 1,235.70 +0.0%
Divi's Laboratories Ltd. 97,460.15 3,668.25 -0.4%
Cipla Ltd. 97,091.96 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. 91,293.11 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. 79,752.32 5,544.70 -0.1%
Mankind Pharma Ltd. 76,862.91 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. 70,347.58 2,075.00 +1.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.84 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-09 73.18 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-09 28.12 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 17.93 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.34 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 59.96 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.73 2,075.00 +1.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.98 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-09 7.69 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-09 3.91 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.58 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.27 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 9.12 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.49 2,075.00 +1.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 0.02 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,075.00 +1.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,075.00 +1.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,075.00 +1.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,075.00 +1.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,075.00 +1.0%

Balaxi Pharmaceuticals Ltd. FAQ's

What is Balaxi Pharma. share price?
Can I buy Balaxi Pharma. shares now?
What is the Market Cap of Balaxi Pharma.?
What are the key metrics to analyse Balaxi Pharma.?
What is the 52 Week High and Low of Balaxi Pharma.?
What is the trend of Balaxi Pharma. share price?